Clinical Trials in Detroit

Showing 15901-15920 of 19,719 trials

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

NCT00141297

PD-0332991 may work in cancer by stopping cancer cells from multiplying. PD-0332991 is in a new class of drugs called cyclin-dependent kinase (CDK inhibitors). This research study is the first time that PD-0332991 will be given to people. PD-0332991 is taken by mouth daily.

NeoplasmsLymphoma, Non-Hodgkin

Pfizer74 participantsStarted Sep 2004

Detroit, Michigan, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 1< 1 mile

Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies

NCT00310895

The purpose of this study is to determine the safety and the maximum tolerated dose of GRN163L administration in treating patients with refractory or relapsed solid tumor malignancies.

Solid Tumor Malignancies

Geron Corporation85 participantsStarted Mar 2006

Chicago, Illinois, United States • Detroit, Michigan, United States

TERMINATEDPhase 312 miles

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

NCT02258867

The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).

Behcet's Disease Uveitis

XOMA (US) LLC4 participantsStarted Nov 2014

Santa Ana, California, United States • Chicago, Illinois, United States • Ellsworth, Maine, United States +5 more locations

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Find Trials by Condition in Detroit

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Imexon for Relapsed Follicular and Aggressive Lymphomas

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)